Cryo-Cell International vs Charming Medical
CCEL and MCTA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CCEL and MCTA compare
Cryo-Cell International grew revenue faster over the last twelve months (−2.0% versus −22.7% for Charming Medical).
Charming Medical keeps more of each dollar of sales as profit, with a net margin of −0.47% compared with −6.2% at Cryo-Cell International.
Charming Medical scores higher on the StockData Score (3 against 2 for Cryo-Cell International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CCEL | MCTA |
|---|---|---|
| Size and price | ||
| Market cap | $39.1M | – |
| Share price | $4.85 | $29.35 |
| Change, 1 year | 19.8% | 33.3% |
| Change, 5 years | −60.4% | – |
| Beta (5Y) | 0.26 | 0.85 |
| Employees | 72 | 29 |
| StockData Score | ||
| Total score | 2 | 3 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.3× | – |
| EV/EBITDA | 41.0× | – |
| P/FCF | 8.4× | – |
| FCF yield | 11.9% | – |
| Growth | ||
| Revenue growth (TTM) | −2.0% (better) | −22.7% |
| Revenue growth, 5Y average | 0.27% | – |
| Net income growth (TTM) | – | −102% |
| EPS growth (TTM) | – | −100% |
| Profitability | ||
| Gross margin | 78.5% | 99.3% (better) |
| Operating margin | 0.61% (better) | −0.61% |
| Net margin | −6.2% | −0.47% (better) |
| FCF margin | 14.9% (better) | −32.4% |
| Return on equity | – | −0.87% |
| Return on invested capital | – | −13.7% |
| Financial health | ||
| Debt / equity | – | 0.04 |
| Net debt / EBITDA | 3.65 | – |
| Interest coverage | 0.1× (better) | −1.9× |
| Current ratio | 0.86 | 1.89 (better) |
| Altman Z-score | −0.06 | – |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 6.9% | 0.24% |
| Held by insiders | 41.7% | 71.9% |
| Short interest, % of float | 0.26% | 11.5% |
Go deeper
- CCEL stock overview
- CCEL income statement
- CCEL valuation and score
- MCTA stock overview
- MCTA income statement
- MCTA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.